Dr. Lina Farhat, Deputy Director of Medical Device Evaluation at the National Agency for Pharmaceutical Materials, has been appointed to a key position at the African Medicines Agency (AMA). According to a statement by the Ministry of Pharmaceutical Industry, Dr. Farhat was officially appointed as an expert and deputy head of the Technical Committee for Medical Devices and Diagnostics at the AMA during the 1st AMA Week. The event took place in Kigali, Rwanda, from October 25 to 30, 2026.
The appointment was made in recognition of Dr. Farhat's scientific and regulatory expertise, as well as the effective contribution of the National Agency for Pharmaceutical Materials to the harmonization of regulatory frameworks for pharmaceutical supervision at the African level. This appointment strengthens Algeria's representation in continental technical bodies. The AMA Week's theme, "Building a future of regulation in Africa together... from national strength to continental impact," reflects the agency's commitment to enhancing regulatory capacity in Africa.
The National Agency for Pharmaceutical Materials has played a significant role in promoting regulatory harmonization across Africa. The agency's efforts have focused on ensuring the quality and safety of medical products, which is critical for public health. Dr. Farhat's appointment is expected to further enhance Algeria's influence in shaping regulatory policies at the continental level.
The African Medicines Agency was established to improve access to quality, safe, and effective medicines in Africa. The agency works closely with national regulatory authorities to strengthen regulatory capacity and promote harmonization. Dr. Farhat's expertise in medical device evaluation will be invaluable in supporting the agency's mission.
The 1st AMA Week brought together stakeholders from across Africa to discuss key issues related to pharmaceutical regulation. The event provided a platform for experts to share knowledge, best practices, and experiences in regulating medical products. Dr. Farhat's participation in the event was seen as a significant opportunity for Algeria to engage with continental regulatory issues.
Algeria has been actively involved in promoting pharmaceutical development and regulation in Africa. The country has made significant investments in its pharmaceutical sector, with a focus on improving access to quality medicines. Dr. Farhat's appointment reflects Algeria's commitment to contributing to continental efforts to strengthen regulatory capacity.
The Ministry of Pharmaceutical Industry has expressed its satisfaction with Dr. Farhat's appointment, highlighting the recognition of Algeria's expertise in pharmaceutical regulation. The ministry is expected to continue supporting Dr. Farhat in her new role, ensuring that Algeria remains a key player in shaping regulatory policies at the continental level.
Key points
- Dr. Lina Farhat's appointment to the African Medicines Agency strengthens Algeria's representation in continental technical bodies.
- The appointment recognizes Algeria's expertise in pharmaceutical regulation and its contribution to regulatory harmonization in Africa.
- Dr. Farhat's expertise in medical device evaluation will support the African Medicines Agency's mission to improve access to quality, safe, and effective medicines in Africa.
